CorMedix Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - CRMDAccesswire • 03/28/25
CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of CorMedix Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 03/28/25
Lost Money on CorMedix Inc.(CRMD)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationAccesswire • 03/26/25
CorMedix Inc. (CRMD) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky InvestigatesAccesswire • 03/26/25
INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLCGlobeNewsWire • 03/25/25
CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 03/25/25
CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallBenzinga • 03/24/25
CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025GlobeNewsWire • 03/18/25
CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business UpdateGlobeNewsWire • 01/07/25
CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug ProductsGlobeNewsWire • 11/26/24
CorMedix (CRMD) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 11/08/24
Wall Street Analysts See a 52.15% Upside in CorMedix (CRMD): Can the Stock Really Move This High?Zacks Investment Research • 11/04/24
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 10/30/24